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Abstract 
Background: Human milk fortifier (HMF) is defined as a supplement added to 
breastmilk to increase various nutrition of breastmilk. The purpose of HMF 
administration is to increase the concentration of breastmilk nutrients to improve the 
weight of very low birth weight preterm infants. The administration of HMF is 
insufficient to fulfill protein needs in 20-40% very low birth weight babies, thus the 
weight gain did not meet the expected target.  
Objective: To compare between very low birth weight preterm infants who 
experienced weight gain according to the target and not according to the target on the 
administration of HMF. 
Methods: An observational study with cross sectional design was done to determine 
characteristic differences of very low birth weight preterm infants.  
Results: Data were obtained from medical records consisted of 26 very low birth 
weight premature infants who experienced weight gain according to the target and 26 
who experienced weight gain not according to the target. There was no characteristic 
difference of cyanosis (PR 1.43; 95% CI 0.51-10.4), chest retraction (PR 1.0; 95% CI 
0.32-3.1), apnea of prematurity comorbid (PR 1.0; 95% CI 0.25-3.9), neonatal 
infections (PR 0.79; 95% CI 0.21-1.9), starting age of HMF administration (PR 0.78; 
95% CI 0.21-1.89), bloating (PR 0.74; 95% CI 0.17-1.9), and vomiting (PR 1.09; 95% 
CI 0.38-3.7) in both groups. 
Conclusion: There was no characteristic difference between very low birth weight 
preterm infants who experienced weight gain according to the target and not according 
to the target on the administration of HMF.  
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INTRODUCTION 
 Very low birth weight preterm infant is defined as a 
baby born with a birth weight less than 1500 grams and 
a gestation period of fewer than 37 weeks. Very low birth 
weight preterm infant is one of the most important 
predictors of infant mortality, especially in the first 
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 Very low birth weight preterm infants also play a 
crucial role as significant predictors of infant and child 
morbidity, especially neurodevelopmental disorders such 
as mental retardation and learning disorders. Besides, 
very low birth weight preterm infants are reported to be 
100 times more likely to die in the first year of life than 
infants with normal birth weight.1 
 The prevalence of very low birth weight preterm 
infants is expected to increase globally. Several reports 
showed that very low birth weight preterm infants occurs 
in 4-8% of live births but cause one-third of deaths in the 
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weight preterm infants are a group of infants with high 
morbidity and mortality rates and are the main cause of 
death in 60% of neonates. The prevalence of very low 
birth weight preterm infants varies in several regions in 
Indonesia. Several studies that took place in seven 
regions in Indonesia, namely Aceh, Palembang, 
Yogyakarta, Surabaya, Bali, Ujung Pandang, and 
Manado, showed that the prevalence of very low birth 
weight preterm infants ranges from 2.1-17.7%.3 
 Very low birth weight preterm infants are a special 
population with several distinctive characteristics. 
Cyanosis and chest retraction are known clinical 
symptoms of very low birth weight preterm infants. 
Several researches showed that the prevalence of 
cyanosis in very low birth weight preterm infants was 
around 7.5% while chest retractions estimated to occur 
in 2% to 13% of very low birth weight preterm infants.4,5 
Neonatal infections and apnea of prematurity (AOP), 
which are defined as a cessation of breathing for > 20 
seconds or a shorter pause accompanied by bradycardia 
<100 beats per minute, are also often found in very low 
birth weight preterm infants. Drinking intolerance 
symptoms such as bloating and vomiting are often found 
in very low birth weight preterm infants due to immature 
gastrointestinal tract function.6,7 
 Research shows that breastfeeding, which is the best 
nutrition source for infants, cannot meet the nutritional 
needs of very low birth weight preterm infants if given 
without fortification. The nutritional composition 
contained in the breast milk of mothers who give birth to 
very low birth weight preterm infants is similar to 
mothers who give birth to full-term babies about three to 
four weeks after birth. Therefore, the increased 
nutritional needs of very low birth weight preterm 
infants cannot be met by unfortified breast milk alone.8 
An example of this case is breast milk which contains 
260 mg/L of calcium. Accordingly, if very low birth 
weight preterm infants breastfed at the normal volume 
(for example, around 200 mL/kg/day), unfortified breast 
milk can only provide about 50 mg/kg/day of calcium. It 
can only be met one-third of the total calcium needs of 
very low birth weight preterm infants, assuming a 
maximum absorption rate of 60% to 70%.9 
 Based on the problems above, breast milk must be 
fortified with various substances, especially protein, 
calcium, and phosphate, to meet very low birth weight 
preterm infants' nutritional needs. The other importance 
of breast milk fortification is supported by the fact that 
inadequate protein intake in very low birth weight 
preterm infants can cause growth retardation and lead to 
decreased fat-free mass (FFM). This ultimately leads to 
low neurocognitive development. Therefore, breastmilk 
fortification with a human milk fortifier (HMF) is now 
widely used to meet very low birth weight preterm 
infants' nutritional needs.10 
 HMF is defined as a dietary supplement added to 
breast milk to increase the content of calories, minerals, 
protein, vitamins, and various nutrients in breast milk.11 
The goal of HMF supplementation is to increase the 
nutrient concentration of breast milk to meet very low 
birth weight preterm infants' nutritional needs. The 
nutritional needs of very low birth weight preterm 
infants are defined as the nutritional intake that can cause 
the growth rate of very low birth weight preterm infants 
equal to normal infants' growth rate. The composition of 
HMF may vary between countries, but some substances 
that can always be found in HMF include long-chain fatty 
acids, minerals, vitamins, and amino acids.12 
 The onset of HMF administration can affect the 
weight gain outcome of very low birth weight preterm 
infants. Research conducted by Tillman et al. showed that 
early onset of HMF administration before ten days gave 
better anthropometric measurement results than late 
onset administration.13 This result is supported by a study 
conducted by Alizadeh et al. who reported that early 
onset administration resulted in faster weight gain than 
late onset. Research conducted by Alizadeh et al. 
recommends early fortification in infants less than ten 
days old.14 
 Several reports, however, suggest that HMF 
administration to very low birth weight preterm infants, 
both early and late onset administration, still failed to 
achieve weight gain as expected target. Previous research 
stated that giving HMF was still unable to meet the 
protein needs of 20-40% of very low birth weight preterm 
infants, so that the increase of weight could not reach the 
expected target.15 Research conducted by Picaud et al. in 
2017 indicates that in addition to HMF supplementation, 
some very low birth weight preterm infants still need 
additional protein supplements to achieve weight gain as 
an expected target.16  
 This study was conducted to examine the 
characteristic differences between very low birth weight 
preterm infants who experience weight gain according to 
the target and not according to the target on the 
administration of HMF. The characteristic differences 
consist of cyanosis, chest retraction, AOP, neonatal 
infections, HMF starting age, and drinking intolerance 
symptoms. The purpose of this study is to analyze 
characteristic differences between very low birth weight 
preterm infants who experienced weight gain according 
to the target and not according to the target on the 
administration of HMF. 
 
MATERIALS AND METHODS  
 This study includes an analytical study using a cross 
sectional approach to determine characteristic 
differences found in very low birth weight preterm 
infants who experience weight gain according to the 
target and not according to the target on the 
administration of human milk fortifier (HMF). This 
research was conducted at Dr. Kariadi Hospital, 
Semarang. Data collection and analysis were carried out 
from June to July 2020. Sampling was carried out by a 
consecutive sampling method from medical records of 
very low birth weight preterm infants at Dr. Kariadi 
Hospital, Semarang. Using this method, every neonate 
who met the research criteria was included in the study 
until the minimum sample size was reached. The 
minimum sample size was determined using the unpaired 
case control sample size formula. Based on this formula, 
the minimum sample size was 52.  
 The inclusion criteria used in this study were very low 
birth weight preterm infants who experienced weight 
gain according to and not according to the target on the 
administration of HMF treated in Dr. Kariadi Hospital 
Semarang from January 2019 to January 2020. Weight 
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grams/kg/day as recommended by the American 
Academy of Pediatrics Committee on Nutrition and the 
Nutrition Committee of the Canadian Pediatrics Society. 
The exclusion criteria were infants with major 
congenital abnormalities, infants with necrotizing 
enterocolitis, and infants who died at the end of 
hospitalization. The independent variables in this study 
were cyanosis, chest retraction, apnea of prematurity, 
neonatal infections, HMF supplementation starting age, 
bloating, and vomiting. The dependent variables in this 
study were the weight gain of very low birth weight 
preterm infants on the administration of HMF. Data 
analysis includes descriptive analysis and hypothesis 
testing. Proportion and percentage were used in 
descriptive analysis while Chi-square test was used for 
hypothesis testing. Research protocol declared to be 
ethically appropriate by the Health Research Ethics 
Committee of Faculty of Medicine, Diponegoro 




 This research was conducted at Dr. Kariadi Hospital 
Semarang from the period of June 2020 to July 2020. 
The samples were obtained from medical records and 
were selected by consecutive sampling. There are 52 
samples, with 26 very low birth weight preterm infants 
who experienced weight gain according to the target and 
26 babies who experienced weight gain not according to 
the target on the administration of HMF. Based on the 
respondents' characteristics, it was found that the mean 
gestational age of very low birth preterm infants' weight 
was 30.7 weeks with a standard deviation of 2.5 weeks. 
The median value of the respondent's birth weight was 
1280 grams (700-1450 grams), with the lowest birth 
weight being 700 grams and the highest birth weight 
being 1450 grams. The median value of infants’ birth 
body length was 39 cm (32–43 cm), with the lowest birth 
length was 32 cm and the highest body length at birth 
was 43 cm. It also shows that 76.9% of very low birth 
weight preterm infants were babies born from a singleton 
pregnancy. Most of the very low birth weight preterm 
infants were born to mothers aged between 20 and 35 
years (82.7%) and were multigravida mothers (69.2%). 
Table 1 also shows that the majority of very low birth 
weight preterm infants were born to mothers who had 
comorbidities (63.5%). 
 Table 2 shows clinical symptoms characteristic 
differences of very low birth weight preterm infants who 
experienced weight gains according to the target and not 
according to the target on the administration of HMF. In 
table 2, it can be seen that clinical symptoms of cyanosis 
are more common in the very low birth weight preterm 
infants who experienced weight gain not according to the 
target group. Cyanosis occurs as much as 23.1% in very 
low birth weight preterm infants who experienced 
weight gain not according to the target group compared 
to the group of very low birth weight preterm infants 
who experienced an increase in body weight according 
to the target group which is 11.5%. However, based on 
the chi-square test, the clinical symptoms of cyanosis in 
the two groups are not statistically significant [p = 0.271; 
PR = 1.43 (0.51-10.4)]. There was also no statistically 
difference in chest retraction between two groups [p = 
1,000; PR = 1 (0.32-3.1)]. 
 The results of very low birth weight preterm infants' 
comorbid that underwent increased weight gain 
according to the target and not according to the target are 
shown in table 3. Looking at this table, it can be 
concluded that there is no significant difference between 
the two groups. 
 Chi-square and Mann Whitney test analysis for the 
starting age of HMF administration revealed in table 4. 
Mann Whitney test analysis showed a p-value of > 0.05 
so it can be concluded that there is no significant 
difference in the starting age of HMF administration in 
the two groups. Similar to the Mann Whitney test 
analysis, the Chi-square test also showed no statistically 
significant difference in the starting age of HMF in both 
groups. 
 Drinking intolerance characteristics of very low birth 
weight preterm infants in both groups which consist of 
bloating and vomiting can be seen in table 5. According 
to this table, it can be concluded that there is no 
significant difference in both groups. 
 




















































Gestational Age 31.0 ± 26 
weeks 
30.4 ± 2.3 
weeks 
0.323‡ 












      Singleton 17 (65.4%) 23 (88.5%) 
0.048¥* 
      Multiple 9 (34.6%) 3 (11.5%) 
Mother's age    
< 20 or > 35 years 3 (11.5%) 6 (23.1%) 
0.465¥ 
      20 - 35 years 23 (88.5%) 20 (76.9%) 
Gravida    
      Primigravida 10 (38.5%) 6 (23.1%) 
0.229¥ 
      Multigravida 16 (61.5%) 20 (76.9%) 
Comorbidities    
      Exist 17 (65.4%) 16 (61.5%) 
0.773¥ 
      Absence 9 (34.6%) 10 (38.5%) 
Mean ± SD; Median (min-maks); * Significant (p < 0,05); ‡ 
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Table 2. Differences in clinical symptoms 
Table 3. Comorbid differences  
DISCUSSION  
 Data analysis between very low birth weight preterm 
infants who experienced weight gain according to the 
target and not according to the target on the 
administration of human milk fortifier (HMF) did not 
show much of a difference. Data from the respondents' 
characteristics showed a statistically significant 
difference between singleton and multiple pregnancies 
in the two groups. Most very low birth weight preterm 
infants who experienced weight gain not according to the 
target are babies born from multiple pregnancies. The 
hypothesis behind this is babies born from multiple 
pregnancies are less likely to receive adequate nutrition 
due to the placenta's limited ability, especially during 
late gestation.17 Another hypothesis stated that mothers 
who carry multiple babies are more likely to experience 
pregnancy complications such as anemia and 
preeclampsia.18 
 Other statistically significant characteristics are birth 
weight and birth length. The group with weight gain 
according to the target tends to have smaller birth weight 
and smaller birth length. These characteristics are 
different from the group experiencing weight gain that is 
not according to the target. This study's results are 
consistent with the research conducted by Kupers et al., 
whose finding reveals that babies with a lower birth 
weight have a more significant increase rate of body 
weight than babies with higher birth weight. Kupers et al. 
proposed a concept called "the lower the birth weight, the 
more rapid the growth." According to this concept, 
infants with low birth weight tend to experience rapid 
weight gain, mainly due to low muscle mass, which 
changes muscle sensitivity to insulin.19 This study's 
results, however, are not in accordance with the study 
conducted by Ehsanpour S et al., which found that a 
slower growth rate is observed in babies with lower birth 
weight.20 
 Cyanosis is a bluish discoloration of the skin and 
mucous membranes due to a decrease in hemoglobin 
levels ≥ 5 g/dL which indicates a decrease in blood 
oxygen supply to the tissue.21 This study found that the 
incidence of cyanosis was more common in the group of 
very low birth weight preterm infants who experience 
weight gain not according to the target, although it was 
not statistically significant. This finding is in accordance 
with the study conducted by Irving S. et al. according to 
which there was no growth rate and weight gain 
difference between infants who have cyanosis and infants 
who do not have cyanosis.22 
 Another possibility that resulted in the absence of 
significant differences between the two groups in terms 
of cyanosis is edema that often coexist with cyanosis. 
Cyanosis is caused primarily by a congenital heart 
disease, which results in low systemic blood saturation 
and a bluish discoloration around the mouth or fingers. 
Babies who have end-stage congenital heart disease may 
also develop heart failure often manifesting as edema. 
Edema ultimately affects the measurement of very low 
birth weight preterm infants' weight who have cyanosis.23 
 Chest retraction means that the child is having to use 
chest muscles to get air into the lungs and this condition 
indicates an increased effort to breathe. Analysis of chest 
retraction clinical symptom showed that there was no 
statistically significant difference in very low birth 
weight preterm infants who experienced weight gain 
according to the target and not according to the target on 
the administration of HMF. Therefore, the results of this 
study are not in accordance with the research conducted 
by Ivana K. et al. which states that there is a negative 
correlation between the incidence of chest retraction and 
infants' growth rate.24 
 This insignificant difference is probably due to the 
high incidence of chest retraction in very low birth weight 
preterm infants. The condition that often causes chest 
retraction in very low birth weight preterm infants 
includes respiratory distress syndrome (RDS). 
Respiratory distress syndrome (RDS) is defined as 
respiratory distress due to the lack of surfactant resulting 
in alveoli collapses.25 High incidence of pneumonia in 
very low birth weight preterm infants also significantly 
increases chest retraction incidence in both groups.26
 Apnea of prematurity (AOP) is described as a 
cessation of breathing for 20 seconds or longer or a 
shorter pause accompanied by bradycardia <100 beats 
per minute, cyanosis, or pallor.27 Oxygen and nutrient 
insufficiency should result in weight gain disorders thus 
















Cyanosis     
      Exist 6 (23.1%) 3 (11.5%) 
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1.43 (0.51-






      Exist 17 (65.4%) 17 (65.4%) 
1.000¥ 
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      Exist 10 (38.5%) 13 (50%) 
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 This present study cannot demonstrate the above 
theory because of the high incidence of central nervous 
system immaturity in premature babies, which often 
causes AOP in both groups.28 
 The absence of statistically significant differences of 
AOP in both groups can also be based on the research 
conducted by Mathew et al. The research suggests that 
AOP, notably obstructive and mixed type AOP, is found 
more frequently during sleep.29 As an infant sleeps, 
upper airway muscle activity is reduced, causing the 
upper airway to collapse, mainly during inspiration. The 
existence of poor-quality sleep causes an increased 
ghrelin hormone and decreased leptin hormone. Ghrelin 
plays a significant role in increasing appetite, food 
intake, and reducing energy expenditure by lowering fat 
catabolism, while leptin plays a significant role in 
decreasing appetite. This hormonal balance disorder 
may ultimately cause babies who experience AOP to still 
gain weight according to the target despite having 
AOP.30 
 Neonatal infection is defined as the presence of 
microorganisms in body tissues followed by host 
immune response and is closely associated with infants' 
decreased growth rate.31 This study showed that there is 
no statistically significant difference between both 
groups. This study's results, which did not find any 
statistically significant differences, may be caused by 
several factors. The first possibility was based on 
research conducted by Eleonora P. et al. and Amos T. et 
al., which found a significant relationship between 
infection and accelerated weight gain.32,33 Amos T. et al. 
states that infection causes an adipocyte stress response, 
adipocyte dysfunction, and dysregulation of adipokine 
secretion, which ultimately increase the weight of infants 
who have the infection.33 The second possibility is based 
on research conducted by Dawson-Hahn et al., who 
stated that the use of antibiotics in the first year of life 
significantly increased the rate of infants' weight gain 
compared to the infants who did not take antibiotics.34 
 This study also found that there is no statistically 
significant difference in terms of the starting age of HMF 
administration in both groups. This study's results are 
consistent with a study conducted by Peymaneh A et al. 
according to which there was no significant difference in 
weight gain between very low birth weight preterm 
infants who received early and later HMF 
supplementation.14 The results of this study were also 
supported by research conducted by Wesam A et al. 
whose conclusion states that there was no significant 
difference in weight gain between groups of infants who 
received early and later HMF.13 
 This study found that there is no significant difference 
in drinking intolerance, consisting of bloating and 
vomiting between both groups. However, Fanaro S et al. 
have a different view. They stated that very low birth 
weight preterm infants who experience weight gain not 
according to the target tend to have drinking intolerance 
symptoms.35 Morton et al., who aimed to evaluate growth 
in infants with drinking intolerance also found that 
drinking intolerance resulted in lesser weight gain.  







Not According to 




Average HMF Starting Age 
(days) 13.23 ± 5.3
 13.92 ± 6.7 0.406‡ - 
HMF Starting Age     
       10 days 9 (34.6%) 12 (46.2%) 
0.397¥ 0.78 (0.21-1.89) 
      >10 days 17 (65.4%) 14 (53.8%) 
Mean ± SD ‡; Independent t-test; ¥ Chi-Square test 
 







Not According to The 
Target (n=26) 
According to The 
Target (n=26) 
Bloating     
      Exist 6 (23.1%) 9 (34.6%) 
0.358¥ 0.74 (0.17-1.9)       Absence 20 (76.9%) 17 (65.4%) 
Vomiting     
      Exist 10 (38.5%) 9 (34.6%) 
0.773¥ 1.09 (0.38-3.7) 
      Absence 16 (61.5%) 17 (65.4%) 
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 It is interesting to note that Morton et al. found that 
the weight gain rate in the group of very low birth weight 
infants with drinking intolerance was 19.97 g/kg/day, 
with an increase in body length of 0.81 cm/week during 
three months of hospitalization. The growth rate, then, 
also increased up to 20.56 g/kg/day after three months of 
age.36 
 Growth rates of infants with drinking intolerance 
symptoms in Morton's research are still much greater 
than the weight gain target set in this study, which is 15 
g/kg/day. This finding indicates, despite having 
symptoms of drinking intolerance, infants with the 
registered symptoms are still able to gain weight 
according to the target set by the American Academy of 
Pediatrics Committee on Nutrition and the Nutrition 
Committee of the Canadian Pediatrics Society.36 Other 
factors could also cause insignificant difference between 
both groups in terms of drinking intolerance. Excessive 
drinking, crying for too long, improper breastfeeding 
and drinking process, incorrect position while 
breastfeeding, and excessive lactose can eventually 
cause bloating. Similar to bloating, vomiting can also be 
caused by other conditions such as a small stomach size, 
incorrect position when breastfeeding, or infections.37 
 This study has several limitations. The first limitation 
is that other common comorbid in very low birth weight 
preterm infants, such as hyperbilirubinemia and 
congenital heart disease, were not studied. These factors 
can affect the weight gain of very low birth weight 
preterm infants and thus influence the results of the 
study. Samples taken from medical records also have 
limitations. Data taken from medical records are less 
representative and cannot fully describe patient's current 




 In conclusion, our study demonstrated that there was 
no characteristic differences in terms of cyanosis and 
chest retraction clinical symptoms, apnea of prematurity 
and neonatal infections comorbid, starting age of HMF 
administration, and drinking intolerance symptoms 
which consists of bloating and vomiting between very 
low birth weight preterm infants who experienced 
weight gain according to the target and not according to 
the target on the administration of HMF. Further 
research which includes other variables that can affect 
the growth rate of very low birth weight preterm infants 
such as hyperbilirubinemia and congenital heart disease 
may be needed to obtain more accurate results. 
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